Open AccessA randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan ® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension
Author(s) -
Arun Narayanaswamy,
Aditya Neog,
Mani Baskaran,
Ronnie George,
Lingam Vijaya,
Chetan Desai,
Viraj Rajadhyaksha
Publication year - 2007
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/0301-4738.30707
Subject(s) - medicine , latanoprost , tolerability , ocular hypertension , intraocular pressure , open angle glaucoma , glaucoma , adverse effect , ophthalmology , crossover study , randomized controlled trial , placebo , alternative medicine , pathology
To compare the efficacy and tolerability of Xalatan with generic latanoprost (Latoprost) in subjects with primary open angle glaucoma (POAG) or ocular hypertension (OH).